Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Human Vaccines & Immunotherapeutics
|
March 18, 2026
Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study
Michael Smolinski, Jo Lin Chew, Cora Constantinescu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 25, 2021
An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis
Gabor Forgo, Evy Micieli, Walter Ageno, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 11, 2020
Canadian stroke best practice recommendations: <i>Management of Spontaneous Intracerebral Hemorrhage</i>, 7th Edition Update 2020
Ashkan Shoamanesh, M Patrice Lindsay, Lana A Castellucci, et al.
Blood Advances
|
June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
Philip S Wells, Tobias Tritschler, Faizan Khan, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 6, 2025
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism
Duale Omar, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey
Nicola Potere, Isabelle Mahé, Pantep Angchaisuksiri, et al.
JAMA
|
March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 20, 2023
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
Nathaniel R Smilowitz, Erinn M Hade, Lucy Z Kornblith, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 15, 2021
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
Stefano Barco, Luca Valerio, Andrea Gallo, et al.
BMJ (Clinical Research Ed.)
|
March 24, 2022
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)
Michael Fralick, Michael Colacci, Laveena Munshi, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Human Vaccines & Immunotherapeutics
|
March 18, 2026
Hematologic adverse events following COVID-19 vaccination and revaccination in persons aged 12 and above: A Canadian Immunization Research Network study
Michael Smolinski, Jo Lin Chew, Cora Constantinescu, et al.
Journal of Thrombosis and Haemostasis : JTH
|
November 25, 2021
An update on the global use of risk assessment models and thromboprophylaxis in hospitalized patients with medical illnesses from the World Thrombosis Day steering committee: Systematic review and meta-analysis
Gabor Forgo, Evy Micieli, Walter Ageno, et al.
International Journal of Stroke : Official Journal of the International Stroke Society
|
November 11, 2020
Canadian stroke best practice recommendations: <i>Management of Spontaneous Intracerebral Hemorrhage</i>, 7th Edition Update 2020
Ashkan Shoamanesh, M Patrice Lindsay, Lana A Castellucci, et al.
Blood Advances
|
June 9, 2022
Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism
Philip S Wells, Tobias Tritschler, Faizan Khan, et al.
Journal of Thrombosis and Haemostasis : JTH
|
August 6, 2025
Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism
Duale Omar, Michael J Kovacs, Alejandro Lazo-Langner, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 6, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey
Nicola Potere, Isabelle Mahé, Pantep Angchaisuksiri, et al.
JAMA
|
March 21, 2023
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
Ewan C Goligher, Patrick R Lawler, Thomas P Jensen, et al.
Research and Practice in Thrombosis and Haemostasis
|
September 20, 2023
Effect of therapeutic-dose heparin on severe acute kidney injury and death in noncritically ill patients hospitalized for COVID-19: a prespecified secondary analysis of the ACTIV4a and ATTACC randomized trial
Nathaniel R Smilowitz, Erinn M Hade, Lucy Z Kornblith, et al.
Research and Practice in Thrombosis and Haemostasis
|
July 15, 2021
Global reporting of pulmonary embolism-related deaths in the World Health Organization mortality database: Vital registration data from 123 countries
Stefano Barco, Luca Valerio, Andrea Gallo, et al.
BMJ (Clinical Research Ed.)
|
March 24, 2022
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE)
Michael Fralick, Michael Colacci, Laveena Munshi, et al.
Page
of 11